Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men

AIDS

Volumn 11, Issue 11, 1997, Pages 1383-1388

  Spijkerman, Ingrid J B ^a,c   Prins, Maria ^a   Goudsmit, Jaap ^a   Veugelers, Paul J ^a   Coutinho, Roel A ^a   Miedema, Frank ^a,b   De Wolf, Frank ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

AIDS free; HIV 1 RNA; Long term; Progression to AIDS; Surrogate markers

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS TITRATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PROSPECTIVE STUDIES; RNA, VIRAL; SURVIVORS; T-LYMPHOCYTES;

EID: 0030841540     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199711000-00013     Document Type: Article

References (22)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
2. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
3. Pialak M, Saag MS, Yang LC, et al.: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
4. Hogervorst E, Jurriaans S, de Wolf F, et al.: Predictors for non-and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995, 171:811-821.
5. Jurriaans S, Van Gemen B, Weverling GJ, et al.: The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994, 204:223-233.
6. Mellors JW, Kingsley LA, Rinaldo Jr CR, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
7. Lafeuillade A, Lamalet C, Pellegrino P, De Micco P, Vignoli C, Quilichini R: Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 1994, 7:1028-1033.
8. Pantaleo G, Menzo S, Vaccarezza M, et al.: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995, 332:209-216.
9. Cao Y, Qin L, Zhang L, Safrit I, Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995, 332:201-208.
10. Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley IA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
11. Lee T, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP: Circulating HIV-1 infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994, 7:381-388.
12. Henrard DR, Daar L, Farzadegan H, et al.: Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:305-310.
13. van Griensven GJP, Lielman RAP, Goudsmit J, et al.: Risk factors and prevalence of HIV antibodies in homosexual men in The Netherlands. Am J Epidemiol 1987, 125:1048-1057.
14. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36:1S-15S.
15. Schellekens PTA, Roos MIL, de Wolf F, Lange JMA, Miedema F: Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 infected men. J Clin Immunol 1990, 10:121-127.
16. Koot M, Vos AH, Keet RPM, et al.: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
17. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PML, van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990, 28:495-503.
18. Miedema E, Meyaard L, Koot M, et al.: Changing virus-host interactions in the course of HIV-1 infection Immunol Reviews 1994, 140:35-72.
19. Sheppard HW, Lang W, Ascher MS, Vittinghoff F, Winkelstein W: The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 1993, 7:1159-1166.
20. keet IPM, Krol A, Klein MR, et al.: Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 1994, 169:1236-1243.
21. Roos MFI, Miedema F, Koot M, et al.: T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995, 171:531-536.
22. Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L: Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis 1996, 173:1388-1393.